Filtros de búsqueda

Lista de obras de Lucia Del Mastro

5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial

artículo científico publicado en 2015

A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer

artículo científico publicado en 2010

A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer

artículo científico publicado en 1994

A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes

article

Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes

artículo científico publicado en 2011

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

scientific article published on 26 November 2018

Adjuvant chemotherapy in breast cancer

artículo científico publicado en 1995

Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications

artículo científico publicado en 1997

Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and beta2-microglobulin downregulation in breast cancer.

artículo científico publicado en 2009

Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.

artículo científico publicado en 2015

Anthracycline-free therapy for HER2-amplified breast cancer.

artículo científico publicado en 2013

Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients

artículo científico

Aromatase Inhibitors As Adjuvant Therapy for Breast Cancer

artículo científico publicado en 2009

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study

artículo científico publicado en 2012

Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole

artículo científico publicado en 2014

Body weight and return to work among survivors of early-stage breast cancer

artículo científico publicado en 2020

Call for ensuring cancer care continuity during COVID-19 pandemic

scientific article published on 01 May 2020

Cancer and fertility preservation: international recommendations from an expert meeting

artículo científico publicado en 2016

Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma

artículo científico publicado en 2003

Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study

artículo científico publicado en 2020

Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.

artículo científico publicado en 2011

Corrigendum to “Gene expression profiling in breast cancer: A clinical perspective” [The Breast 22 (2013) 109–120]

article

Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial

artículo científico publicado en 2005

Dose-dense sequential administration and same day administration of epirubicin and paclitaxel yield similar response rates in women with advanced breast cancer

Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial

artículo científico

Effects of CERA (continuous erythropoietin receptor activator) in patients with advanced non-small-cell lung cancer (NSCLC) receiving chemotherapy: results of a phase II study.

artículo científico publicado en 2010

Endocrine therapy in premenopausal women with breast cancer: a critical appraisal of current evidence

artículo científico publicado en 2015

Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.

artículo científico publicado en 2016

Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer.

artículo científico publicado en 1996

Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors

artículo científico publicado en 2010

Everolimus-based therapy in patients with hormone receptor-positive, HER2(-) advanced breast cancer: management considerations

artículo científico publicado en 2015

Exploring the safety of chemotherapy for treating breast cancer during pregnancy

artículo científico

Fertility counseling of young breast cancer patients

artículo científico publicado en 2013

Fertility issues in young breast cancer patients: what women want

artículo científico publicado en 2014

Fertility preservation strategies for breast cancer patients.

artículo científico publicado en 2006

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

article

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

artículo científico publicado en 2015

Follow-up of patients with early breast cancer: is it time to rewrite the story?

artículo científico publicado en 2014

Gene expression profiling in breast cancer: a clinical perspective.

artículo científico

Gonadotropin-Releasing Hormone Analogue for Premenopausal Women With Breast Cancer—Reply

artículo científico publicado en 2011

Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials

artículo científico publicado en 2013

Hexaprimer amplification refractory mutation system PCR for simultaneous single-tube genotyping of 2 close polymorphisms

scientific article published on 01 January 2008

Hormone Receptor/Human Epidermal Growth Factor Receptor 2-positive breast cancer: Where we are now and where we are going

artículo científico publicado en 2016

Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients

artículo científico publicado en 2001

Impact of chemotherapy dose-density on radiotherapy dose-intensity after breast conserving surgery

artículo científico publicado en 2001

Impact of two different dose-intensity chemotherapy regimens on psychological distress in early breast cancer patients.

artículo científico publicado en 2002

Infertility and pregnancy after breast cancer: current knowledge and future perspectives

artículo científico publicado en 2006

Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients

artículo científico publicado en 2003

Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients

artículo científico publicado en 2001

Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study

artículo científico publicado en 2002

Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?

scientific article published on 17 December 2015

Lapatinib concentration in cerebrospinal fluid in two patients with HER2-positive metastatic breast cancer and brain metastases

scientific article published on 01 April 2014

Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.

artículo científico publicado en 2008

Letrozole withdrawal response in locally advanced breast cancer

artículo científico publicado en 2011

Long-Term Follow-Up of the Intergroup Exemestane Study ⬇️

artículo científico publicado en 2017

Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancer

artículo científico publicado en 2017

Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: current role and future perspectives.

artículo científico publicado en 2010

Maintenance hormone therapy with letrozole after first-line chemotherapy for advanced breast cancer

artículo científico publicado en 2005

Medical approaches to preservation of fertility in female cancer patients.

scientific article published on February 2011

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

artículo científico publicado en 2006

New emerging targets in cancer immunotherapy: the role of GITR

artículo científico publicado en 2020

New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients.

artículo científico publicado en 2015

News on the medical treatment of young women with early-stage HER2-negative breast cancer

artículo científico publicado en 2016

Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients

artículo científico publicado en 2005

Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors

artículo científico

Oral chemotherapy and patient perspective in solid tumors: a national survey by the Italian association of medical oncology

artículo científico publicado en 2015

Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial

artículo científico publicado en 2015

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

artículo científico publicado en 2015

Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer.

artículo científico publicado en 2009

Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study.

artículo científico publicado en 2015

Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial

artículo científico publicado en 2015

Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.

artículo científico publicado en 2015

Pharmacokinetics of trastuzumab in haemodialysis.

artículo científico publicado en 2015

Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer

artículo científico publicado en 2013

Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole. ⬇️

artículo científico publicado en 2012

Predicting mood disorders in breast cancer patients.

artículo científico publicado en 2001

Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients

artículo científico publicado en 2005

Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence

artículo científico publicado en 2015

Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial

artículo científico publicado en 2020

Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments.

artículo científico publicado en 2013

Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

artículo científico publicado en 2007

Reducing the risk of distant metastases in breast cancer patients: role of aromatase inhibitors

artículo científico publicado en 2007

Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy ⬇️

artículo científico publicado el 15 de octubre de 1994

Reply to A. Sánchez-Muñoz et al

Reply to the letter to the editor ‘Can ovarian suppression with gonadotropin releasing hormone analogs (GnRHa) preserve fertility in cancer patients?’ by Rodriguez-Wallberg et al

artículo científico publicado en 2015

Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies

artículo científico publicado en 2016

Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel

artículo científico publicado en 2007

Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients

artículo científico publicado en 2016

Safety of adjuvant aromatase inhibitor therapy.

artículo científico publicado en 2006

Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective

artículo científico publicado en 2004

Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer

artículo científico publicado en 2005

Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients.

artículo científico publicado en 2000

Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer

artículo científico publicado en 1990

Stevens-Johnson syndrome after treatment with bendamustine

artículo científico publicado en 2012

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

artículo científico publicado en 2007

Tamoxifen and the endometrium: findings of pelvic ultrasound examination

scientific article published on 01 January 1998

Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer

artículo científico publicado en 2022

Targeting bone metastatic cancer: Role of the mTOR pathway

artículo científico

Taxane-containing chemotherapy in the treatment of early breast cancer patients

artículo científico publicado en 2006

Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

artículo científico publicado en 2015

Temporary Ovarian Suppression With Goserelin and Ovarian Function Protection in Patients With Breast Cancer Undergoing Chemotherapy

artículo científico publicado en 2011

Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology

artículo científico publicado en 2016

The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy

artículo científico publicado en 2016

The difficult decision-making process for using or not using adjuvant chemotherapy in premenopausal endocrine-responsive breast cancer patients

artículo científico publicado en 2008

The five "Ws" for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs).

artículo científico publicado en 2013

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.

artículo científico publicado en 2016

The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study

article

Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy

artículo científico publicado en 2001

Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group

artículo científico publicado en 2007

Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients

artículo científico

Trastuzumab before breast surgery: is concurrent administration with anthracycline-containing chemotherapy necessary?

artículo científico publicado en 2010

Trastuzumab emtansine (T-DM1) as adjuvant treatment of HER2-positive early breast cancer: safety and efficacy

artículo científico publicado en 2020

Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

artículo científico publicado en 2013

Trastuzumab quantification in serum: a new, rapid, robust ELISA assay based on a mimetic peptide that specifically recognizes trastuzumab.

artículo científico publicado en 2014

Treatment of breast cancer during pregnancy: Regimen selection, pregnancy monitoring and more … ⬇️

artículo científico publicado el 15 de diciembre de 2010

Treatment with aromatase inhibitors and markers of cardiovascular disease.

artículo científico publicado en 2016

Update on the Management of Breast Cancer during Pregnancy

artículo científico publicado en 2020

Use in current clinical practice of 70-gene signature in early breast cancer

article

Weekly Paclitaxel in Elderly Patients with Advanced Breast Cancer

scientific article published on 01 January 2004

Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer).

artículo científico publicado en 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda